摘要
目的观察分析全麻复合硬膜外阻滞用于COPD患者手术的临床疗效。方法将本院收治需手术治疗的226例COPD患者按随机数表法均分为A、B两组,各113例,A组患者使用单纯性全麻,B组使用全麻复合硬膜外阻滞,观察记录麻醉效果和患者耐受情况,以及术中生命体征改变及术后并发症。结果两组在起效时间、苏醒时间和脉压差方面差异有统计学意义(P<0.05);A组患者手术前后肺功能降低程度大于B组(P<0.05);术后疼痛分级和满意度差异有统计学意义(P<0.05),A组出现11例COPD急性发作,B组出现3例COPD急性发作,两组差异有统计学意义(P<0.05)。结论全麻复合硬膜外阻滞能有效用于COPD患者手术,具有安全高效的特点。
Objective To observe the clinical efficacy of GEA for surgery of patients with COPD. Methods Two hun- dred and twenty-six patients with COPD were randomly divided into two groups with 113 cases in each group. 113 cases in group A were given general anesthesia, other 113 eases in group B were given GEA. And then the dates of patients intraoperative and postoperative were collected, as well as changes in vital signs and complications were ob- served and recorded. Results The difference between 2 groups of the onset time, wake-up time and pulse pressure was statistically significant (P 〈 0.05); the reduce of lung function in group A was greater than group B (P 〈 0.05); the dif- ference of postoperative pain grading and satisfaction was statistically significant (P 〈 0.05); in group A, 11 cases with acute exacerbation of COPD after surgeon, which was 3 cases in group B (P 〈 0.05). Conclusion GEA for COPD patients' surgery is safe and efficient.
出处
《中国当代医药》
2013年第9期91-92,共2页
China Modern Medicine